Bifogade filer
Johan Wewel appointed as CFO of Ortivus
Kurs & Likviditet
Prenumeration
Kalender
| 2025-02-14 | Bokslutskommuniké 2024 |
| 2024-11-08 | Kvartalsrapport 2024-Q3 |
| 2024-08-23 | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2024-05-10 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2024-05-08 | Årsstämma 2024 |
| 2024-05-08 | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | Bokslutskommuniké 2023 |
| 2023-11-10 | Kvartalsrapport 2023-Q3 |
| 2023-08-25 | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2023-05-05 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2023-05-04 | Kvartalsrapport 2023-Q1 |
| 2023-05-04 | Årsstämma 2023 |
| 2023-02-17 | Bokslutskommuniké 2022 |
| 2022-11-11 | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2022-05-06 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2022-05-05 | Årsstämma 2022 |
| 2022-04-27 | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | Bokslutskommuniké 2021 |
| 2021-11-12 | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2021-05-06 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2021-05-05 | Årsstämma 2021 |
| 2021-04-27 | Kvartalsrapport 2021-Q1 |
| 2021-02-16 | Bokslutskommuniké 2020 |
| 2020-11-10 | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | Kvartalsrapport 2020-Q2 |
| 2020-05-13 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2020-05-13 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2020-05-04 | Årsstämma 2020 |
| 2020-04-23 | Kvartalsrapport 2020-Q1 |
| 2020-02-18 | Årsstämma 1 |
| 2020-02-13 | Bokslutskommuniké 2019 |
| 2020-02-13 | Årsstämma 1 |
| 2019-10-25 | Årsstämma 1 |
| 2019-08-22 | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2019-05-07 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2019-05-06 | Årsstämma 2019 |
| 2019-05-03 | Kvartalsrapport 2019-Q1 |
| 2019-02-18 | Extra Bolagsstämma 2019 |
| 2019-02-13 | Bokslutskommuniké 2018 |
| 2018-11-20 | Kvartalsrapport 2018-Q3 |
| 2018-08-24 | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2018-05-04 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2018-05-03 | Årsstämma 2018 |
| 2018-04-30 | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | Bokslutskommuniké 2017 |
| 2017-11-21 | Kvartalsrapport 2017-Q3 |
| 2017-08-22 | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | Extra Bolagsstämma 2017 |
| 2017-05-02 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2017-05-02 | Kvartalsrapport 2017-Q1 |
| 2017-05-02 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2017-04-28 | Årsstämma 2017 |
| 2017-02-10 | Bokslutskommuniké 2016 |
| 2016-10-24 | Kvartalsrapport 2016-Q3 |
| 2016-07-13 | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | Årsstämma 2016 |
| 2016-05-02 | Kvartalsrapport 2016-Q1 |
| 2016-04-30 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2016-04-30 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2016-02-10 | Bokslutskommuniké 2015 |
| 2015-10-20 | Kvartalsrapport 2015-Q3 |
| 2015-07-13 | Kvartalsrapport 2015-Q2 |
| 2015-04-30 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2015-04-30 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2015-04-29 | Kvartalsrapport 2015-Q1 |
| 2015-04-29 | Årsstämma 2015 |
| 2015-02-17 | Bokslutskommuniké 2014 |
| 2014-10-27 | Kvartalsrapport 2014-Q3 |
| 2014-07-11 | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2014-04-30 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2014-04-29 | Årsstämma 2014 |
| 2014-04-29 | Kvartalsrapport 2014-Q1 |
| 2014-02-07 | Bokslutskommuniké 2013 |
| 2013-10-18 | Kvartalsrapport 2013-Q3 |
| 2013-07-12 | Kvartalsrapport 2013-Q2 |
| 2013-04-30 | Kvartalsrapport 2013-Q1 |
| 2013-04-22 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2013-04-22 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2013-04-19 | Årsstämma 2013 |
| 2013-02-08 | Bokslutskommuniké 2012 |
| 2012-10-18 | Kvartalsrapport 2012-Q3 |
| 2012-07-12 | Kvartalsrapport 2012-Q2 |
| 2012-05-04 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2012-05-04 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2012-05-03 | Årsstämma 2012 |
| 2012-04-20 | Kvartalsrapport 2012-Q1 |
| 2012-02-22 | Bokslutskommuniké 2011 |
| 2011-10-14 | Kvartalsrapport 2011-Q3 |
| 2011-08-12 | Kvartalsrapport 2011-Q2 |
| 2011-05-31 | Extra Bolagsstämma 2010 |
| 2011-05-05 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2011-05-05 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2011-05-04 | Årsstämma 2011 |
| 2011-04-15 | Kvartalsrapport 2011-Q1 |
| 2011-02-18 | Bokslutskommuniké 2010 |
| 2010-10-14 | Kvartalsrapport 2010-Q3 |
| 2010-08-12 | Kvartalsrapport 2010-Q2 |
| 2010-05-04 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2010-05-04 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2010-05-03 | Årsstämma 2010 |
| 2010-04-22 | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | Bokslutskommuniké 2009 |
| 2009-11-12 | Kvartalsrapport 2009-Q3 |
| 2009-08-14 | Kvartalsrapport 2009-Q2 |
| 2009-05-07 | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2009-05-07 | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2009-05-06 | Årsstämma 1 |
| 2009-05-06 | Kvartalsrapport 2009-Q1 |
| 1998-04-23 | Split ORTI A 1:2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Ortivus has recruited Johan Wewel as the new Chief Financial Officer and a member of the company's management team.
Ortivus is pleased to announce the appointment of Johan Wewel as the new Chief Financial Officer (CFO). Johan brings nearly three decades of experience in executive positions within companies characterized by profitable growth.
"We are very pleased to welcome Johan Wewel to our team! Johan's extensive and diverse experience from leading positions in growth companies with a focus on profitability will be of great importance to Ortivus." says Gustaf Nordenhök, Ortivus’ CEO.
From 2017 to 2021, Johan served as CFO at Frösunda Omsorg, where he gained valuable experience in a listed environment through the company's financing via listed bonds. Johan's work has primarily focused on service-producing companies, but he also has experience in production and international sales.
In addition to his extensive operational experience in financial management, financing and corporate transactions, Johan has worked as a senior advisor at Carlsquare, providing financial advisory services and assisting clients with mergers and acquisitions, listings, and equity market analysis.
Most recently, Johan held the position of CFO at Ecoclime Group.
“I am excited to join Ortivus at such a pivotal time in its journey,” says Johan Wewel. “I look forward to working closely with the talented team at Ortivus to drive financial excellence and contribute to the company’s success.”
Johan will assume the role of Ortivus CFO on September 1, 2024.
Contacts
For further information, please contact
Gustaf Nordenhök, CEO
Telefon +46 8 446 45 00
About Ortivus
Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.
MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.
MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.
Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-06-25 07:30 CEST.